Fexapotide Triflutate for Benign Prostatic Hyperplasia

Fexapotide triflutate is an investigational injectable apoptotic agent proposed for the treatment of benign prostatic hypertrophy (BPH).

If you have a Hayes login, click here to view the full report on the Knowledge Center.